Yuyu Pharma, Inc. (KRX:000220)
South Korea · Delayed Price · Currency is KRW 4,490.00
+10.00 (0.22%)
At close: Jul 31, 2025, 3:30 PM KST
Yuyu Pharma Market Cap
Yuyu Pharma has a market cap or net worth of 70.56 billion as of August 1, 2025. Its market cap has decreased by -5.73% in one year.
Market Cap
70.56B
Enterprise Value
71.93B
Revenue
132.65B
Ranking
n/a
PE Ratio
14.36
Stock Price
4,490.00
Market Cap Chart
Since August 31, 1995, Yuyu Pharma's market cap has increased from 11.10B to 70.56B, an increase of 535.45%. That is a compound annual growth rate of 6.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 70.56B | -3.22% |
| Dec 30, 2024 | 72.90B | -14.68% |
| Dec 28, 2023 | 85.44B | -16.84% |
| Dec 29, 2022 | 102.75B | -21.01% |
| Dec 30, 2021 | 130.08B | 20.22% |
| Dec 30, 2020 | 108.20B | 62.16% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.15T |
| Celltrion | 39.70T |
| ALTEOGEN | 24.13T |
| Yuhan | 8,960.21B |
| SK Biopharmaceuticals | 7,815.66B |
| Peptron | 6,709.64B |
| HLB Co., Ltd. | 6,302.85B |
| PharmaResearch | 5,714.31B |